Condition: Systemic Lupus Erythematosus · Sponsor: Zenas BioPharma (USA), LLC
This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).
This description comes directly from the study's public registry record.
Patient and Medical Information · 833-269-4696 · clinicaltrialsinfo@zenasbio.com
Always discuss trial participation with your own doctor first.
| Sierra Pacific Arthritis and Rheumatology Centers | Fresno, California, United States | Recruiting |
| California Research Institute | Huntington Park, California, United States | Recruiting |
| University of California, San Diego | La Jolla, California, United States | Recruiting |
| Clinical Research of West Florida, Inc | Clearwater, Florida, United States | Recruiting |
| Clinical Research of West Florida, Inc. | Tampa, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Accurate Clinical Research | Lake Charles, Louisiana, United States | Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
| June DO, PC | Lansing, Michigan, United States | Recruiting |
| Juno DO, PC | Lansing, Michigan, United States | Recruiting |
| DJL Clinical Research PLLC | Charlotte, North Carolina, United States | Recruiting |
| Oklahoma Medical Research Foundation | Oklahoma City, Oklahoma, United States | Recruiting |
+ 70 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06559163